GG
Geno J Germano
Director

Geno J Germano insider trades: Precision Biosciences (DTIL) stock buys and sales

Director, Precision Biosciences Last trade Sep 25, 2026 97 Form 4 filings
$0
Sold, last 12 months
0 sales
$60K
Bought, last 12 months
3 buys
9
Open-market trades
since 2008
11
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Geno reports to the SEC

and 5 more companies

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 25, 2026DTIL↑ Buy$16K
Feb 10, 2026ENTX↑ Buy$30K
Dec 16, 2025DTIL↑ Buy$14K
Mar 25, 2025DTIL↑ Buy$17K
Dec 30, 2024DTIL↑ Buy$16K
Jun 2, 2014PFE↓ Sell$890K
Mar 14, 2013PFE↓ Sell$1.1M
Feb 6, 2013ZTS↑ Buy$130K
Nov 25, 2008WYE↓ Sell$179K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other DTIL insiders

Open-market trades in the last 12 months

About Geno J Germano's insider trades

Geno J Germano is a director at Precision Biosciences (DTIL). Since Nov 25, 2008, Geno has reported 6 open-market purchases worth $224K and 3 sales worth $2.2M on SEC Form 4. In the last 12 months: 3 buys ($60K).

Their filings also include grants and awards (78 filings), shares withheld for taxes (7 filings), shares returned to the company (5 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DTIL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.